Implementing monitoring programs and objective measurement tools can help address gaps in Annex 1 compliance. What remains is embedding those tools within a program architecture designed to generate, interpret, and act on objective data systematically, across the full life cycle of the contamination control strategy (CCS). This article highlights what a well-constructed Annex 1-compliant program looks like at each stage, from gap assessment through governance, and how USP measurement tools integrate at each step.
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
1.877.787.0177
510.732.0177
Pharmatech Associates, Inc. 9110 Alcosta Blvd. STE H #601 San Ramon CA 94583
